For those curious as to what went down before Jeff Kindler unexpectedly resigned last December as the Pfizer ceo, a new treatise in Fortune magazine offers a behind-the-scenes look at the political infighting, overblown aspirations and inept calculations that contributed to his demise, as well as a decade of disappointment and a few spectacular failures at the big drugmaker.
For Kindler, the end came in a plain vanilla Florida airport conference room where he was confronted by three board members, who - after probing a steady stream of confidential reports that his managerial style was overbearing, his behavior was increasingly erratic and his judgment was questionable - decided he must go. Essentially, he was given an ultimatum - with a lot of money.